Loss of bronchoprotection to Salbutamol during sputum induction with hypertonic saline: implications for asthma therapy

Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Hong-Yu WangParameswaran Nair

Abstract

Sputum induction with hypertonic saline in obstructive airway diseases is generally safe. However, saline induces bronchoconstriction in some patients despite pre-medication with Salbutamol. Our objectives were to investigate the predictors of failure of Salbutamol to protect against saline-induced-bronchoconstriction in patients with asthma and COPD and to evaluate implications for asthma therapy. Retrospective survey on a database of 3565 patients with obstructive airway diseases who had sputum induced with hypertonic saline. The effect of baseline FEV1, bronchitis and concomitant medication on saline-induced-bronchoconstriction (≥ 15% drop in FEV1) were examined by logistic regression analysis. A subgroup had this re-examined 8-12 weeks after decreasing long-acting-beta-2-agonist dose or after adding Montelukast, which included an assessment of mast cell activity in sputum. 222 (6.2%) patients had saline-induced-bronchoconstriction despite pre-treatment with inhaled Salbutamol. Baseline airflow obstruction (FEV1% predicted < 60% OR 3.29, p < 0.001) and long-acting-beta-agonist use (OR 2.02, p = 0.001), but not bronchitis, were predictors of saline-induced-bronchoconstriction, which decreased when long-acting-beta-agonist dos...Continue Reading

References

Sep 1, 1995·American Journal of Respiratory and Critical Care Medicine·P J Barnes
Aug 1, 1996·American Journal of Respiratory and Critical Care Medicine·E PizzichiniF E Hargreave
Oct 9, 1999·The European Respiratory Journal·R J HancoxD R Taylor
Jul 11, 2000·The Journal of Allergy and Clinical Immunology·V A SwystunD W Cockcroft
Jan 12, 2001·The European Respiratory Journal·H Vlachos-MayerF E Hargreave
Sep 11, 2001·American Journal of Respiratory and Critical Care Medicine·A ten BrinkeE H Bel
Dec 19, 2003·The European Respiratory Journal·I E ZühlkeH Magnussen
Apr 13, 2005·Respiratory Medicine·Sarah Haney, Robert J Hancox
Jul 1, 2017·The European Respiratory Journal·Bronwyn S BerthonKatherine J Baines
Aug 2, 2017·The Journal of Allergy and Clinical Immunology·Pieter-Paul HekkingUNKNOWN U-BIOPRED Study Group

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

SPSS
PASW Statistics

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.